Procrit causes lethal side effects
Is it true that Procrit causes lethal side effects?
Partly. The safety profile of Procrit (epoetin alfa) remains a subject of ongoing clinical debate, with some studies pointing to cardiovascular risks and potential mortality concerns, while others report acceptable safety and manageable side effects in clinical practice.
Verdict: CONTESTED · 2 sources for, 2 against · Last checked
The retrieved papers present mixed findings regarding the safety of erythropoiesis-stimulating agents like Procrit (epoetin alfa). Some sources highlight safety concerns, cardiovascular risks, and potential mortality harms, while other clinical trials and reviews emphasize reassuring post-approval data and acceptable safety profiles. This division of evidence across the provided literature warrants a CONTESTED verdict.
The evidence we hold leans evenly split
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
- Mortality Risk of Darbepoetin Alfa versus Epoetin Alfa in Pa · peer-reviewed · supports · weight 1.3 · 2015
- Personalized Therapeutic Advances in Erythropoietin Signalin · peer-reviewed · supports · weight 1.05 · 2025
- Erythropoiesis-Stimulating Agents in the Management of Anemi · peer-reviewed · refutes · weight 1.3 · 2018
- Efficacy and safety of recombinant human erythropoietin (Hem · peer-reviewed · refutes · weight 1.05 · 2021
Get citation
Wilhelm-Leen, E. R. & Winkelmayer, W. (2015). Mortality Risk of Darbepoetin Alfa versus Epoetin Alfa in Patients with Chronic Kidney Disease: Systematic Review and Meta-Analysis. doi.org. https://doi.org/10.1053/j.ajkd.2014.12.012
Get citation
M, A., P, G., K, P., GM, R., S, F., Jr, A. L., & J, W. (2018). Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective.. doi.org. https://doi.org/10.3389/fphar.2018.01498
See more details
Get citation
EC, C., R, S., AC, N., CM, D., & IB, D. (2025). Personalized Therapeutic Advances in Erythropoietin Signaling: From Anemia Management to Extensive Clinical Applications.. doi.org. https://doi.org/10.3390/pharmaceutics17091190
Get citation
Chuengsaman, P., Narenpitak, S., & Sritippayawan, S. (2021). Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. doi.org. https://doi.org/10.5527/wjn.v10.i6.109
- Is it true that Codeine causes dry mouth as a side effect? SUPPORTED
- Is it true that artificial oxytocin produces specific physiological effects and side effects? SUPPORTED
- Is it true that Bempedoic acid does not increase the risk of muscle-related side effects? SUPPORTED
- Is it true that Adderall causes dry mouth as a common side effect? SUPPORTED
- Is it true that side effects compromise the blinding in clinical studies? SUPPORTED
What does the evidence say?
The retrieved papers present mixed findings regarding the safety of erythropoiesis-stimulating agents like Procrit (epoetin alfa). Some sources highlight safety concerns, cardiovascular risks, and potential mortality harms, while other clinical trials and reviews emphasize reassuring post-approval data and acceptable safety profiles. This division of evidence across the provided literature warrants a CONTESTED verdict.
Receipt History
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work